DEPO Insider Trading Activity and SEC Form 4 Filings
DEPO insider trading summary
No open-market insider purchases or sales of Depomed Inc (DEPO) have been reported on SEC Form 4 in the past 12 months.
Latest DEPO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 11, 2018 | Matthew M Gosling | SVP, General Counsel | Sell | $139K (19,674 @ $7.07) |
| Mar 7, 2018 | Matthew M Gosling | SVP, General Counsel | Sell | $300K (45,519 @ $6.58) |
| Dec 14, 2017 | Arthur J Higgins | President and CEO | Buy | $612K (75,000 @ $8.16) |
| Jun 13, 2017 | Thadd M Vargas | SVP, Business Development | Sell | $190K (19,816 @ $9.60) |
| Jun 13, 2017 | Thadd M Vargas | SVP, Business Development | Sell | $1.5M (160,820 @ $9.53) |
| Jun 13, 2017 | Thadd M Vargas | SVP, Business Development | Sell | $209K (21,751 @ $9.59) |
| Jun 12, 2017 | Arthur J Higgins | President and CEO | Buy | $149K (15,000 @ $9.92) |
| May 11, 2017 | Matthew M Gosling | SVP, General Counsel | Sell | $673K (59,212 @ $11.37) |
| May 11, 2017 | Thadd M Vargas | Senior VP, BD | Sell | $601K (50,000 @ $12.03) |
| Nov 14, 2016 | August J Moretti | Chief Financial Officer & SVP | Sell | $104K (5,000 @ $20.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.